25th Annual Controversies in the Management of the Patient with HIV

Friday, Dec 2, 2022 at 10:00 AM to 4:00 PM EST

1300 York Avenue, New York, New York, 10065, United States

Register Now
Days
Hours
Minutes
Seconds

Registration

Sale ended

In-Person General Admission Partial Approval - $30.00

In-Person General Admission Registration fee to be paid to Weill Cornell Medicine inclusive of: admission to program, course materials and refreshments.

sales ended

Virtual General Admission Partial Approval - $30.00

Virtual attendance via ZOOM registration fee to be paid to Weill Cornell Medicine inclusive of: admission to program and course materials.

Enter your discount code

  • Subtotal (excluding fees and discounts)
  • Fee
  • Total amount

1. Select Seats

2. Review and Proceed

Friday, Dec 2, 2022 at 10:00 AM to 4:00 PM EST

Uris Auditorium, 1300 York Avenue, New York, New York, 10065, United States.

Weill Cornell Medicine - Division of Infectious Diseases is proud to present our 25th Annual Controversies in the Management of the Patient with HIV. 

This year's conference marks our 25 years providing clinical education on HIV/AIDS, and this full day conference will provide attendees with information on:

  1. The history of HIV and how the epidemic has evolved over the past 40+ years
  2. HIV and Adolescents highlighting HIV prevention and treatment options
  3. Sexually transmitted infections (STIs) and HIV
  4. Antiretroviral Therapy treatment options and what's on the horizon
  5. Pre-Exposure Prophylaxis (PrEP) and what the future holds
  6. Co-Morbities and HIV
  7. HIV Cure Update

Target Audience: The conference is intended for primary care providers (internists, family care practitioners) and infectious disease and HIV specialists, including, physicians, nurse practitioners and physician assistants. Anyone who is interested in this program is welcome to attend.

*REGISTRATION FEE: $30 (Free for Residents, Fellows and Medical Students)

*Registration fee to be paid to Weill Cornell Medicine inclusive of: admission to program and course materials (lunch will be provided for in-person attendees).

Accreditation Statement: Weill Cornell Medical College is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Weill Cornell Medical College designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 Upon successful completion of this course, Weill Cornell Medical College will submit your completion data to ABIM via ACCME’s Program and Activity Reporting System (PARS) for MOC points.

Weill Cornell Medical College

https://medicine.weill.cornell.edu/divisions-programs/infectious-diseases/education/aids-education

25th Annual Controversies in the Management of the Patient with HIV supported by The Arthur Ashe Endowment and the AIDS Education and Training Center (AETC)

Contact the Organizer View other events

Learn more aboutMarshall Glesby, MD, PhD Marshall Glesby, MD, PhD
Marshall Glesby, MD, PhD
Professor of Medicine and Population Health Sciences, Associate Chief, Division of Infectious Diseases
Weill Cornell Medicine
Dr. Glesby is a Professor of Medicine and Healthcare Policy and Research and Regional Director of the Northeast Caribbean AIDS Education and Training Center (AETC). Dr. Glesby trained in internal medicine and in infectious diseases at Johns Hopkins and received a Ph.D. in clinical investigation from the Johns Hopkins School of Hygiene and Public Health. His research interests include metabolic, cardiopulmonary, and aging-related complications in people living with HIV. He also collaborates with colleagues in Brazil on studies of HTLV-I infection and leishmaniasis. Dr. Glesby directs the HIV/AIDS Clinical Trials Unit at Weill Cornell and is the Director of the Clinical and Translational Research Unit Core of Weill Cornell Clinical and Translational Science Center.

About Marshall Glesby, MD, PhD

Professor of Medicine and Population Health Sciences, Associate Chief, Division of Infectious Diseases
Weill Cornell Medicine
Learn more aboutRoy Gulick, MD Roy Gulick, MD
Roy Gulick, MD
Rochelle Belfer Professor of Medicine Chief, Division of Infectious Diseases
Weill Cornell Medicine
Dr. Gulick is the Rochelle Belfer Professor in Medicine and Chief of the Division of Infectious Diseases at Weill Cornell Medicine. Dr. Gulick trained in internal medicine at Columbia and in infectious diseases at Harvard and received his MPH in clinical trial design from the Harvard School of Public Health. His research focuses on clinical trials of antiretroviral therapies for treatment and prevention of HIV infection. Dr. Gulick currently serves as Principal Investigator of the Weill Cornell Medical College-New Jersey Medical School Clinical Trials Unit of the NIH-sponsored AIDS Clinical Trials Group (ACTG). He also serves as Co-Chair of the U.S. Department of Health and Human Services Panel for Clinical Practices for Treatment of HIV Infection (DHHS Guidelines Panel), Chair of NIH Office of AIDS Research Advisory Committee (OARAC) and is a Board Member of the International Antiviral Society-USA. Current projects include evaluating treatment strategies for both antiretroviral therapy-naïve and experienced patients, and using antiretroviral therapy as a prevention strategy (PrEP, pre-exposure prophylaxis).

About Roy Gulick, MD

Rochelle Belfer Professor of Medicine Chief, Division of Infectious Diseases
Weill Cornell Medicine
Learn more aboutAllison Agwu, MD, ScM Allison Agwu, MD, ScM
Allison Agwu, MD, ScM
Professor of Adult and Pediatric Infectious Diseases
Johns Hopkins University School of Medicine
Dr. Allison Agwu, M.D., ScM is Professor of Adult and Pediatric Infectious Diseases at Johns Hopkins University School of Medicine in Baltimore, Maryland. Her clinical care and research focus on deciphering health disparities and optimizing care, treatment strategies, and outcomes particularly for young people at-risk for and/or living with HIV. Dr. Agwu oversees a clinical research program that aims to coordinate care, treatment, and research for vulnerable populations through a multidisciplinary and socially responsible lens. She cares for patients across the age spectrum, both in the pediatric and adult Ryan-White funded HIV clinics at Johns Hopkins, as the founder and medical director of the Accessing Care Early (ACE) Clinic and the Program Director of the Pediatric/Adolescent HIV/AIDS Program. She is also the Project Director of JH-WICY Partnership, a regional RW Part D funded program aimed at improving care for vulnerable populations in central Maryland. Dr. Agwu’ s independent research studies use multimodal approaches, including clinic and field-based/community-involved approaches and clinical trials. She is also involved with large national and international research groups (IMPAACT, ATN, PAVE) where she actively directs the research agenda and approaches. She is an active member of the U.S. Department of Health and Human Services’ Adolescent and Adult Antiretroviral Treatment Guidelines, Vice Chair of the HIV Medicine Association Board of Directors, and Chair of the Advocates for Youth Board, all spaces where she tirelessly advocates for those who often cannot advocate for themselves, especially the youth.

About Allison Agwu, MD, ScM

Professor of Adult and Pediatric Infectious Diseases
Johns Hopkins University School of Medicine
Learn more aboutCarlos del Rio, MD Carlos del Rio, MD
Carlos del Rio, MD
Leon L. Haley, Jr, MD. Distinguished Professor of Medicine
Emory University School of Medicine
Carlos del Rio, M.D., is the Leon L. Haley, Jr, MD. Distinguished Professor of Medicine at Emory University School of Medicine, and professor of global health and epidemiology at the Rollins School of Emory University. He serves as the Executive Associate Dean of Emory University School of Medicine at Grady Health System, and is the co-director and principal investigator of the Emory Center for AIDS Research. His research interests include the early diagnosis of HIV, linkage to and retention in HIV care, and prevention of HIV infection. He has long worked in hospitals and clinics with hard-to-reach populations including substance abuse users to improve outcomes of those infected with HIV and to prevent infection among those at risk.

About Carlos del Rio, MD

Leon L. Haley, Jr, MD. Distinguished Professor of Medicine
Emory University School of Medicine
Learn more aboutLishomwa C. Ndhlovu, MD, PhD Lishomwa C. Ndhlovu, MD, PhD
Lishomwa C. Ndhlovu, MD, PhD
Professor of Immunology in Medicine
Weill Cornell Medicine
Lishomwa (Lish) Ndhlovu MD, PhD is a Professor of Immunology in Medicine in the Division of Infectious Diseases and Neuroscience at the Brain and Mind Research Institute at Weill Cornell Medicine. The thrust of his research program is confronting the challenges of HIV and aging and is developing specific strategies to prevent, slow or eliminate complications associated with HIV. His team combines immunology, virology and epigenetic methods exploring molecular mechanism of HIV pathogenesis and persistence through pre-clinical and clinical investigations and has expanded towards finding an HIV cure. He has also become increasingly involved in bringing the same urgency and focus to the COVID-19 pandemic and exploits immuno-epigenetic approaches to resolve molecular mechanisms regulating SARS-CoV-2 infection across tissues and cell types in people with and without HIV. His lab is largely supported by individual, and consortia grants from the NIH. He is a member of the International Neuro-HIV Cure Consortium and Co-leader of the NIH - funded Martin Delaney Collaboratory for HIV Cure “HOPE” and NIDA funded U01-SCORCH program documenting single cell opioid responses in the brain in the setting of HIV. He is an elected Fellow of the American Academy of Microbiology and serves as Co-Editor in Chief of the journal, AIDS Research and Human Retroviruses.

About Lishomwa C. Ndhlovu, MD, PhD

Professor of Immunology in Medicine
Weill Cornell Medicine
Learn more aboutAnne M. Rompalo, MD, ScM Anne M. Rompalo, MD, ScM
Anne M. Rompalo, MD, ScM
Professor of Medicine
Johns Hopkins University School of Medicine
Anne M. Rompalo, M.D., Sc.M. Dr. Rompalo is a Professor of Medicine and Gynecology at the Johns Hopkins University School of Medicine (JHUSOM), with joint appointments in Epidemiology, International Health and Population, Family and Reproductive Health at the Johns Hopkins Bloomberg School of Public Health. She is Medical Director of the CDC-sponsored Sexually Transmitted Diseases (STD)/HIV Prevention Training Center at Johns Hopkins (PTC), and has previously been Acting Medical Director of the Baltimore City Health Departments STD Clinics and Medical Director of the Office of Population Affairs Male Training Center. She has over 30 years of experience as the Medical Director of the STD/HIV PTC, and has been a key investigator on several studies focused on the natural history of HIV among women including the HERS (HIV Epidemiology Research Study) and several HPTN trials.

About Anne M. Rompalo, MD, ScM

Professor of Medicine
Johns Hopkins University School of Medicine
Learn more aboutShobha Swaminathan, MD Shobha Swaminathan, MD
Shobha Swaminathan, MD
Associate Professor of Medicine
Rutgers, The State University Of New Jersey
Shobha Swaminathan, MD is Associate Professor of Medicine, Director of HIV Programs and the clinical research site leader At Research With a Heart, the NIH-funded clinical trials unit which is part at New Jersey Medical School. Dr. Swaminathan is the principal investigator of many clinical grants to provide HIV testing, care and treatment. Her research interests include clinical trials for HIV treatment and Prevention with a special interest in women's health. She also leads a very active community engagement team dedicated to increasing awareness about HIV and the importance of clinical research in helping to address the HIV epidemic.

About Shobha Swaminathan, MD

Associate Professor of Medicine
Rutgers, The State University Of New Jersey
Learn more aboutHenry Murray, MD Henry Murray, MD
Henry Murray, MD
Arthur R. Ashe Professor of Medicine
Weill Cornell Medical College
Dr. Murray received his BA degree from Cornell University and his MD from Cornell University Medical College. He trained in Internal Medicine at The New York Hospital, where he was also Chief Resident, and at The Johns Hopkins Hospital. He obtained clinical infectious diseases training at George Washington University School of Medicine and post-doctoral research training in immunology at Rockefeller University. In 1979, Dr. Murray returned to the Division of Infectious Diseases at Weill Cornell Medical College where he established his research laboratory in experimental visceral leishmaniasis and host defense which has now been supported by NIH for nearly 30 years, and he was also Division Chief (1983-1995). He established Cornell's NIH AIDS Clinical Trials Group and the Cornell Clinical Trials Unit, and was Associate Chairman for Clinical Research in the Department of Medicine (1995-2007). Dr. Murray established and directs the Arthur Ashe AIDS Endowment, co-chairs the Department's Quality Assurance Committee and formerly co-directed the Kala-Azar Medical Research Center in India. He is editor of Tropimed-U.S., a travel medicine website, and attends on the Infectious Diseases clinical service and at Cornell's Travel Medicine Clinic.

About Henry Murray, MD

Arthur R. Ashe Professor of Medicine
Weill Cornell Medical College

  • test
Clear all ×

Sessions on Dec 02, 2022

09:30 AM

Registration – Lobby, Uris auditorium

09:30 AM - 10:00 AMUris Auditorium
10:00 AM

Opening Comments/Review Agenda

10:00 AM - 10:15 AMUris Auditorium
  • Marshall Glesby, MD, PhD

    Professor of Medicine and Population Health Sciences, Associate Chief, Division of Infectious Diseases

    Weill Cornell Medicine

10:15 AM

Keynote speaker: 40 Plus years of HIV: looking back and planning forward

10:15 AM - 10:55 AMUris Auditorium
  • Carlos del Rio, MD

    Leon L. Haley, Jr, MD. Distinguished Professor of Medicine

    Emory University School of Medicine

10:55 AM

Adolescent HIV: #thriving?

10:55 AM - 11:35 AMUris Auditorium
  • Allison Agwu, MD, ScM

    Professor of Adult and Pediatric Infectious Diseases

    Johns Hopkins University School of Medicine

11:35 AM

STIs in PWH - No big deal, right?

11:35 AM - 12:15 PMUris Auditorium
  • Anne M. Rompalo, MD, ScM

    Professor of Medicine

    Johns Hopkins University School of Medicine

12:15 PM

Lunch Break

12:15 PM - 01:00 PMGriffis Faculty Club
01:00 PM

Henry Murray, MD: Arthur Ashe Endowment

01:00 PM - 01:05 PM
01:05 PM

Future of Antiretroviral Therapy

01:05 PM - 01:45 AMUris Auditorium
  • Roy Gulick, MD

    Rochelle Belfer Professor of Medicine Chief, Division of Infectious Diseases

    Weill Cornell Medicine

01:45 PM

PreP: Current and Future Options

01:45 PM - 02:25 PMUris Auditorium
  • Shobha Swaminathan, MD

    Associate Professor of Medicine

    Rutgers, The State University Of New Jersey

02:25 PM

Break

02:25 PM - 02:35 PM
02:35 PM

Future of Co-Morbidities

02:35 PM - 03:15 PMUris Auditorium
  • Marshall Glesby, MD, PhD

    Professor of Medicine and Population Health Sciences, Associate Chief, Division of Infectious Diseases

    Weill Cornell Medicine

03:15 PM

Update on HIV Cure Efforts

03:15 PM - 03:55 PMUris Auditorium
  • Lishomwa C. Ndhlovu, MD, PhD

    Professor of Immunology in Medicine

    Weill Cornell Medicine

03:55 PM

Closing Remarks

03:55 PM - 04:00 PMUris Auditorium
  • Marshall Glesby, MD, PhD

    Professor of Medicine and Population Health Sciences, Associate Chief, Division of Infectious Diseases

    Weill Cornell Medicine

Comments